Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Klotho Neurosciences, Inc. (KLTO) had Debt to Equity Ratio of 0.23 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-6.15M |
|
-- |
|
-- |
|
$5.54M |
|
$-5.54M |
|
$-0.61M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-5.54M |
|
$-5.53M |
|
19.25M |
|
19.25M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$0.16M |
|
-- |
|
$2.30M |
|
$2.46M |
|
$1.25M |
|
-- |
|
$0.02M |
|
$1.27M |
|
$1.19M |
|
$-1.11M |
|
$1.19M |
|
27.08M |
|
| Cash Flow Statement Financials | |
$-2.95M |
|
$-0.12M |
|
$3.13M |
|
$0.00M |
|
$0.06M |
|
$0.06M |
|
$2.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.23 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-518.87% |
|
551.99% |
|
-250.28% |
|
-518.87% |
|
$0.04 |
|
$-0.15 |
|
$-0.15 |
|